Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2015

01-12-2015 | Editorial

Rumors of the Demise of Peer Review are Premature

Authors: Richard L. Kravitz, MD, MSPH, Mitchell D. Feldman, MD, MPhil

Published in: Journal of General Internal Medicine | Issue 12/2015

Login to get access

Excerpt

“Peer review is faith-based (not evidence-based), slow, wasteful, ineffective, largely a lottery, easily abused, prone to bias, doesn’t detect fraud and irrelevant.” …
Literature
1.
go back to reference Ferreira C, Bastille-Rousseau G, Bennett AM, Ellington EH, Terwissen C, Austin C, et al. The evolution of peer review as a basis for scientific publication: directional selection towards a robust discipline? Biol Rev Camb Philos Soc. 2015. doi:10.1111/brv.12185.PubMed Ferreira C, Bastille-Rousseau G, Bennett AM, Ellington EH, Terwissen C, Austin C, et al. The evolution of peer review as a basis for scientific publication: directional selection towards a robust discipline? Biol Rev Camb Philos Soc. 2015. doi:10.​1111/​brv.​12185.PubMed
2.
go back to reference The Royal Society. Conference on the Future of Scholarly Scientific Communication. London. 2015. The Royal Society. Conference on the Future of Scholarly Scientific Communication. London. 2015.
Metadata
Title
Rumors of the Demise of Peer Review are Premature
Authors
Richard L. Kravitz, MD, MSPH
Mitchell D. Feldman, MD, MPhil
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3518-9

Other articles of this Issue 12/2015

Journal of General Internal Medicine 12/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine